Bristol-Myers, GRYT Health announce new digital pilot
GRYT Health and Bristol-Myers Squibb announced a strategic pilot utilizing de-identified data to integrate patient insights and clinical research with the goal of building a foundation of real-world data that will support improved clinical trial design, disease management and the overall well-being of patients living with cancer. The pilot will provide Bristol-Myers Squibb with valuable insights from patients on their experiences with cancer through GRYT's Stupid Cancer app, the most used patient and caregiver platform in oncology. The app is designed to instantly and anonymously connect people affected by cancer with each other, give them a platform for exchange and empower them with important resources and information. By learning more about how patients experience and manage their disease, Bristol-Myers Squibb and GRYT aim to accelerate health innovations and improve quality of life for patients.